About the Company
Bio-Techne Corporation develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $TECH News
The Bio-Techne Corp (TECH) Stock expansion path ahead
Scotiabank raised the price target for the Bio-Techne Corp (NASDAQ:TECH) stock to “a Sector outperform”. The rating was released on February 08, 2024, according to finviz. The research report from UBS ...
Bio-Techne Corp
Marijuana ETFs have had it rough, but word that cannabis may be reclassified is giving these battered funds new hope.
Bio-Techne Corp. Q3 Profit Decreases, but beats estimates
(RTTNews) - Bio-Techne Corp. (TECH) announced earnings for third quarter that decreased from last year but beat the Street estimates. The company's earnings totaled $49.059 million, or $0.31 per ...
Bio-Techne Corp (TECH) Q3 Fiscal 2024 Earnings: Mixed Results Amid Market Challenges
Warning! GuruFocus has detected 2 Warning Sign with UTHR. On May 1, 2024, Bio-Techne Corp (NASDAQ:TECH) disclosed its financial outcomes for the third quarter of fiscal year 2024, revealing a ...
Bio-Techne Stock (NASDAQ:TECH), Analyst Ratings, Price Targets, Predictions
Bio-Techne Corp has a consensus price target of $137.43, established from looking at the 35 latest analyst ratings. The last 3 analyst ratings were released from Deutsche Bank, Stifel, and ...
Bio-Techne Corp (TECH) (Q3 2024) Earnings Call Transcript Highlights: Navigating Market ...
Revenue: $303.4 million, 2% year-over-year organic growth, 3% reported growth. Net Income: Adjusted EPS $0.48, down from $0.53 year-over-year; GAAP EPS $0.31, down from $0.43 year-over-year.
Bio-Techne Corp Common Stock (TECH)
The Dividend History page provides a single page to review all of the aggregated Dividend payment information. Visit our Dividend Calendar: Our partner, Quotemedia, provides the upcoming ex ...
Bio-Techne Corp BRDR
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Bio-Techne Corp
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...
Bio-Techne Corp TECH
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Loading the latest forecasts...